To evaluate the performance of the blood mSEPT9 assay in the diagnosis of CRC, we plotted ROC curves for cancer against NED compared with CEA and CA19-9, which are the most commonly used blood-based tumor markers in the diagnosis of CRC. This evidence concerns the gene CEACAM5 and colorectal carcinoma.